E2082

DRUG2 trials

Sponsors

Eisai Co., Ltd., Eisai Inc.

Conditions

Healthy ParticipantsPhotosensitive Epilepsy

Phase 1

Study to Assess the Safety, Tolerability, and Pharmacokinetics of E2082 in Healthy Male Subjects

TerminatedNCT03402178

Eisai Co., Ltd.Healthy Participants

Start: 2017-12-21End: 2020-02-20Updated: 2021-06-30

Phase 2

A Study to Evaluate the Pharmacodynamic Activity of E2082 in Adult Participants With Photosensitive Epilepsy

TerminatedNCT03686033

Eisai Inc.Photosensitive Epilepsy

Start: 2018-10-31End: 2019-06-18Updated: 2020-09-28